Author’s Accepted Manuscript Decane-1,2-diol derivatives as potential antitumor agents for the treatment of glioblastoma Anisha Viswanathan, Anastasia Zhurina, Benedicta Assoah, Aleksi Paakkunainen, Aliyu Musa, Dinesh Kute, Konda Mani Saravanan, Olli Yli-Harja, Nuno R. Candeias, Meenakshisundaram Kandhavelu PII: S0014-2999(18)30504-1 DOI: https://doi.org/10.1016/j.ejphar.2018.08.041 Reference: EJP71966 To appear in: European Journal of Pharmacology Received date: 18 May 2018 Revised date: 29 August 2018 Accepted date: 30 August 2018 Cite this article as: Anisha Viswanathan, Anastasia Zhurina, Benedicta Assoah, Aleksi Paakkunainen, Aliyu Musa, Dinesh Kute, Konda Mani Saravanan, Olli Yli-Harja, Nuno R. Candeias and Meenakshisundaram Kandhavelu, Decane-1,2- diol derivatives as potential antitumor agents for the treatment of glioblastoma, European Journal of Pharmacology, https://doi.org/10.1016/j.ejphar.2018.08.041 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting galley proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. www.elsevier.com/locate/ejphar